RBC Capital Upgrades Outset Medical to Outperform, Raises Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has upgraded Outset Medical (NASDAQ:OM) from Sector Perform to Outperform and raised the price target from $5 to $6.
June 21, 2024 | 10:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has upgraded Outset Medical from Sector Perform to Outperform and increased the price target from $5 to $6.
The upgrade from Sector Perform to Outperform and the increase in price target from $5 to $6 by RBC Capital is a positive signal for investors. This suggests that the analyst expects better performance from Outset Medical in the near term, likely leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100